文献速递免疫规划传染病防控与疫情报告

健康人群接种新冠疫苗后SARS-CoV-2特异性体液免疫特征及相关因素分析

Characterization of SARS-CoV-2-specific humoral immunity and associated factors in the healthy population post-vaccination.
PubMed 文献 · Vaccine · 2023-12-15

研究纳入中山大学附属第七医院1217人和深圳宝田医院379人共1596名健康人,其中分别有694人和218人接种两剂新冠灭活疫苗(SC2IV),用非病毒ELISA试剂盒检测中和抗体、Spike IgG、RBD IgG等,多因素分析显示两剂接种可使超90%受者产生中和抗体,年龄是影响中和抗体水平最重要的独立指标。

要点

  • 两剂SC2IV接种可使超过90%的受者产生中和抗体。
  • 中和抗体与抗RBD IgG相关性最强。
  • 年龄是影响中和抗体水平最重要的独立指标,男女间影响因素不同。

核心结论

  • 接种后与中和抗体水平相关的因素可能有助于临床评估疫苗受者的保护效果、再感染风险、症状严重程度和预后。

研究设计与样本

  • 研究纳入中山大学附属第七医院1217人和深圳宝田医院379人共1596名健康人,其中分别有694人和218人接种两剂新冠灭活疫苗(SC2IV)。
  • 记录体检指标,用非病毒ELISA试剂盒检测SARS-CoV-2中和抗体、Spike IgG、RBD IgG、RBD IgG+IgM+IgA和核衣壳IgG,并进行多种统计分析。

主要发现

  • 两剂接种可使超过90%的受者产生中和抗体。
  • 中和抗体与抗RBD IgG相关性最强。
  • 年龄是影响中和抗体水平最重要的独立指标,嗜碱性粒细胞计数、肌酸激酶-MB、平均红细胞血红蛋白、白蛋白与尿肌酐比值和甲状腺球蛋白抗体贡献相对较小。
  • 影响中和抗体水平的指标在男性和女性之间不同。
  • 在无抗RBD抗体的受者中检测到针对SARS-CoV-2其他表位的抗体。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate factors that may influence humoral immunity post-vaccination with a COVID-19-inactivated vaccine (SC2IV). METHODS: A total of 1596 healthy individuals from the Seventh Affiliated Hospital, Sun Yat-sen University (1217) and Shenzhen Baotian Hospital (379) were enrolled in this study among which 694 and 218 participants were vaccinated with two-dose SC2IV, respectively. Physical examination indices were recorded. The levels of neutralizing antibody (NA), Spike IgG, receptor-binding domain (RBD) IgG, RBD IgG + IgM + IgA, and nucleocapsid IgG of SARS-CoV-2 were measured by a non-virus ELISA kit. Multiple statistical analyses were carried out to identify factors that influence humoral immunity post-vaccination. RESULTS: The two-dosage vaccination could induce NA in more than 90 % of recipients. The NA has the strongest correlation with anti-RBD IgG. Age is the most important independent index that affects the NA level, while basophil count, creatine kinase-MB, mean corpuscular hemoglobin, the ratio of albumin to urine creatinine, and thyroglobulin antibody have relatively minor contributions. Indices that affect the NA level were different between males and females. Antibodies targeting other epitopes of SARS-CoV-2 were detected in recipients without anti-RBD. CONCLUSIONS: The factors identified in association with the NA level post-vaccination may help to evaluate the protective effect, risk of re-infection, the severity of symptoms, and prognosis for vaccine recipients in clinical.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zhan XY, Chen Y, Zhang X, et al. Characterization of SARS-CoV-2-specific humoral immunity and associated factors in the healthy population post-vaccination. Vaccine. 2023. PMID: 38103966. doi:10.1016/j.vaccine.2023.12.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。